How to Invest in Neuralink Stock Before Its IPO

Last Updated: Oct 1, 2024

Investor

We mention products and services that we think can be helpful for our users. Some or all of them may be from partners who compensate us. This can influence which topics we choose and how products are presented on the page, but it does not affect our opinions or conclusions.

Neuralink is developing implantable computer chips for the brain, known as brain-computer interfaces (BCIs). The man behind it: Elon Musk.

Neuralink's devices have the potential to treat people who have disabilities of the brain and spine, such as blindness, deafness, memory loss, paralysis, and more.

Beyond medical use cases, the company also believes these devices could “unlock human potential” by linking our brains with the internet, artificial intelligence, and other technologies. If successful, these devices will be revolutionary.

Still, the company is in its infancy, having only begun human trials in January 2024. At this point, the technology is more sci-fi than actual science.

But, if it works, early investors will be rewarded.

And, if you qualify as an accredited investor, there's a way for you to invest in Neuralink right now.

Can you buy Neuralink stock?

Neuralink is a private company, which means it is not a public stock — you cannot purchase shares of it in your regular brokerage account. There is no Neuralink stock symbol, and the company has made no indication of an IPO in the near future.

Given the star power of the founding team, Neuralink has had no problem raising capital from private equity investors and venture capitalists. To date, the company has raised $680 million from investors.

And you may be able to invest right alongside them.

How to Buy Neuralink Stock

Hiive is a marketplace where accredited investors can buy private companies stocks.

Accredited investors are those who have either:

Income of $200,000 (or $300,000 as a joint couple)

A net worth of $1 million excluding their primary residence

If you meet either one of these criteria, you're an accredited investor.

On Hiive, accredited investors can buy shares of private, VC-backed startups. There are hundreds of companies listed on Hiive, including SpaceX, Databricks, and Neuralink:

As of the time of this writing, there are 15 orders of Neuralink stock available on Hiive.

These listings are from different sellers who have various asking prices and volume offered. Sellers may be current or former employees, venture capitalists, or angel investors.

On Hiive, buyers can either accept asking prices or place bids and negotiate directly with the sellers.

Neuralink alternatives for retail investors

If you don't qualify as an accredited investor but want to own companies with similar medical devices being developed, consider the following neurotech and biotech companies:

Amgen (AMGN): Amgen is a $171 billion biotechnology company dedicated to solving neurodegenerative diseases and other neurological conditions. While it's not directly competing with Neuralink to develop BCIs, its Digital Health and Innovation team has kept the company at the leading edge of healthcare.
Biogen (BIIB): Although it is not developing BCIs, Biogen has been developing products for neurological diseases, like Alzheimer's, for years.
AstraZeneca (AZN): AstraZeneca is a biotechnology and pharmaceutical company with a specialized focus on neuroscience, particularly in developing drugs for neurological disorders.

If you're looking for general exposure to biotechnology innovations, you may be interested in ARK Invest's Genomic Revolution ETF (ARKG), though the companies in this fund are working on genomics, not BCIs.

When will Neuralink IPO?

Neuralink has not filed any IPO documents with the SEC and has not mentioned any specific plans to go public.

By staying private, the company can take its time researching and making progress toward its lofty goals without the added pressure of having to answer to shareholders.

In my opinion, the company is unlikely to go public before it has a marketable product and a consistent stream of revenue. I would guess we'll hear about this on Musk's social media accounts before any official filings are made with the SEC.

When it does go public, the stock symbol might be something like LINK, NLNK, or NRLK (my ideas) and you'll need a brokerage account to buy shares.

Most brokerages will start offering the stock for trading on the day of the IPO, usually around 10 a.m. Eastern Time.

If you don't have a brokerage account, we recommend Public.

On Public, you can Invest in stocks, ETFs, Treasuries, and cryptocurrencies, all on one of the most well-designed investing platforms.

Who owns Neuralink?

Elon Musk initially invested $100 million in Neuralink back in 2016 and is still the largest shareholder.

Since then, the company has raised an additional $550 million from a number of private investors such as Google Ventures, ARCH Venture Partners, Craft Ventures, DFJ Growth, Dreamers VC, Future Ventures, Valor Equity Partners, Sam Altman (CEO of OpenAI), and up to 9 other investors and firms.

Most recently, Peter Thiel's Founders Fund led a $280 million round in August 2023. In June, employee stock sales valued the company at $5 billion, so we can assume this round was raised near that valuation.

In addition to Musk, his two co-founders (Max Hodak and Paul Merolla), current CEO Jared Birchall, and a handful of early employees also likely own stakes in the company, though their exact stakes are unknown.

More about Neuralink

At its core, Neuralink is aiming to connect human brains and computers.

Its device, known as the “Link,” will be implanted with an incision by a robotic system that will manage the entire procedure. The device will be about the size of a large coin.

The implant operation will cost around $5,000 and the hardware will cost about $200–$300.

After being implanted, you'll connect the device to your smartphone, keyboard, mouse, or other internet- or Bluetooth-enabled device.

Musk believes the Link will become as essential as a car — everyone will have one. Compared to this, his mission for SpaceX doesn't seem so far-fetched in comparison.

Neuralink valuation chart

As mentioned above, Neuralink was valued at $5 billion in June 2023.

Here's a look at how Neuralink's valuation has changed over time:

Based on secondary market transactions, Neuralink may have been valued at as much as $8 billion in July 2024. Accredited investors can see its current valuation on Hiive.

Any views expressed here do not necessarily reflect the views of Hiive Markets Limited (“Hiive”) or any of its affiliates. Stock Analysis is not a broker dealer or investment adviser. This communication is for informational purposes only, and is not a recommendation, solicitation, or research report relating to any investment strategy, security, or digital asset. All investment involves risk, including the loss of principal and past performance does not guarantee future results. There is no guarantee that any statements or opinions provided herein will prove to be correct. Stock Analysis may be compensated for user activity resulting from readers clicking on Hiive affiliate links. Hiive is a registered broker-dealer and member of FINRA / SIPC. Find Hiive on BrokerCheck.